暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
PMV 制药公司在杰富瑞集团收购时发起
PMV 制药公司在杰富瑞集团收购时发起
道琼斯04/12 09:31 (美东)
杰富瑞以买入评级启动PMV Pharmicals,目标股价为5美元
杰富瑞以买入评级启动PMV Pharmicals,目标股价为5美元。
MT Newswires04/12 08:03 (美东)
快讯 | PMV 制药公司:杰富瑞以买入评级启动保险;目标价为5美元
Moomoo 24/704/12 00:41 (美东)
PMV Pharmicals 在针对TP53 Y220C阳性实体瘤的Rezatapopt的全球肿瘤无关的2期PYNACLE 试验中给首位患者服药
PMV Pharmicals 在针对TP53 Y220C阳性实体瘤的Rezatapopt的全球肿瘤无关的2期PYNACLE 试验中给首位患者服药
Benzinga03/27 08:10 (美东)
奥本海默仍持有PMV制药公司(PMVP)
TipRanks03/19 07:55 (美东)
PMV Pharmicals PYNACLE PYNACLE 在晚期卵巢癌领域的 Rezatapopt I 期数据已在 2024 年 SGO 女性癌症年会上口头陈述
PYNNACLE 1/2期研究的1期分析显示,rezatapopt(PC14586)对具有TP53 Y220C 突变特征的晚期卵巢癌进行了大量预治疗的患者,其疗效令人鼓舞
Benzinga03/18 16:02 (美东)
Trytosaveabit : Crazy how this happens sometimes? The results are actually pretty damn good! Hopefully after the conference and people actually hear the results and direction of trial, this will respond accordingly? I am watching for my in! GL @Alvinnnnnnn89 ! BTW you sir are on fire this week! Congratulations! You do so much for so many! Thank you!
TimeKeeper : @Trytosaveabit @Alvinnnnnnn89 do u think this is good company to hold long term ? Seems now is a good entry.
Trytosaveabit TimeKeeper: I do! GL
暂无数据
暂无数据